论文部分内容阅读
对我院2001-10~2005-08前列腺增生(BPH)和前列腺癌(PC a)患者进行血清总前列腺特异性抗原(T-PSA)、游离前列腺特异抗原(F-PSA)检测,将其检测情况报告如下。1对象和方法1.1对象对我院前列腺疾病患者进行筛选。选择前列腺特异抗原(PSA)在4.0~10.0μg/L范围内BPH和PC a患者92例,其
The total prostate specific antigen (T-PSA) and free prostate-specific antigen (F-PSA) in patients with benign prostatic hyperplasia (BPH) and prostate cancer (PCa) from 2001 to 2005 in our hospital were detected. The situation report is as follows. 1 objects and methods 1.1 object screening of patients with prostate disease in our hospital. Ninety-two BPH and PCa patients with prostate specific antigen (PSA) ranging from 4.0 to 10.0 μg / L